Detalhe da pesquisa
1.
Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning.
Lab Invest
; 101(12): 1585-1596, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489559
2.
Treatment of indolent cutaneous T-cell lymphoma with hypofractionated radiation therapy in three cats.
Vet Dermatol
; 32(5): 515-e143, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34240483
3.
Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.
BMC Cancer
; 17(1): 67, 2017 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28109246
4.
MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
BMC Cancer
; 16(1): 784, 2016 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27724924
5.
Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
BMC Vet Res
; 11: 206, 2015 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26272737
6.
Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis.
BMC Cancer
; 14: 84, 2014 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-24517413
7.
Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines.
BMC Vet Res
; 10: 160, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25022346
8.
Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose.
BMC Vet Res
; 9: 190, 2013 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24079884
9.
Establishment and characterization of two novel patient-derived lines from canine high-grade glioma.
Vet Comp Oncol
; 21(3): 492-502, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254642
10.
AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit.
Blood
; 115(21): 4217-25, 2010 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20233974
11.
Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma.
BMC Vet Res
; 8: 67, 2012 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22630170
12.
Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines.
BMC Vet Res
; 8: 244, 2012 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23244668
13.
Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Genes Chromosomes Cancer
; 50(11): 859-74, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21837709
14.
Canine Apocrine Gland Anal Sac Adenocarcinoma: A Review.
Top Companion Anim Med
; 50: 100682, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35792243
15.
A retrospective analysis of 11 dogs with surface osteosarcoma.
Vet Comp Oncol
; 20(1): 82-90, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033204
16.
Clinical validation of a next-generation sequencing-based multi-cancer early detection "liquid biopsy" blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study.
PLoS One
; 17(4): e0266623, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35471999
17.
Development of a brain metastatic canine prostate cancer cell line.
Prostate
; 71(12): 1251-63, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21321976
18.
Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
BMC Cancer
; 11: 125, 2011 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21481226
19.
The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.
BMC Cancer
; 11: 112, 2011 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21443800
20.
Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma.
Front Vet Sci
; 8: 672361, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34164452